INS and hydrops fetalis: In this case, the estimated 5-year HF rate for patients receiving insulin was 34.8% (95% CI 34.5%‐35.2%), whereas the rate for those receiving DPP-4Is was 22.9% (95% CI 22.5%‐23.3%; Figure S2 in Multimedia Appendix 1).